Zhang Shu-Yang
Chinese Society of Cardiology, Chinese Medical Association; Chinese College of Cardiovascular Physician; Chinese Heart Failure Association of Chinese Medical Doctor Association; Editorial Board of Chinese Journal of Cardiology;This guideline was first published in the Zhonghua Xin Xue Guan Bing Za Zhi 2024; 52(3): 235-275.
J Geriatr Cardiol. 2025 Mar 28;22(3):277-331. doi: 10.26599/1671-5411.2025.03.002.
In the past 6 years, significant breakthroughs have been achieved in the treatment of heart failure (HF), especially in drug therapy. The classification of chronic HF and the treatment methods for HF and its complications are also constantly being updated. In order to apply these results to the diagnosis and treatment of patients with HF in China and further improve the level of diagnosis and treatment of HF in China, the HF Group of Chinese Society of Cardiology, Chinese Medical Association, Chinese College of Cardiovascular Physician, Chinese HF Association of Chinese Medical Doctor Association, and Editorial Board of Chinese Journal of Cardiology have organized an expert group and update the consensus and evidence-based treatment methods in the field of HF based on the latest clinical research findings at home and abroad, combined with the national conditions and clinical practice in China, and referring to the latest foreign HF guidelines while maintaining the basic framework of the .
在过去6年中,心力衰竭(HF)的治疗取得了重大突破,尤其是在药物治疗方面。慢性HF的分类以及HF及其并发症的治疗方法也在不断更新。为将这些成果应用于中国HF患者的诊断和治疗,进一步提高我国HF的诊治水平,中华医学会心血管病学分会心力衰竭学组、中国医师协会心力衰竭专业委员会、中华医学会心血管内科医师分会、中国医师协会心血管内科医师分会心力衰竭专业委员会以及《中华心血管病杂志》编辑委员会组织了专家组,基于国内外最新临床研究结果,结合我国国情和临床实践,参考国外最新HF指南,在保持基本框架的同时更新了HF领域的共识和循证治疗方法。